John C. Rhee
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
Papers in
- Oncology 8
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- William Lee Smith (1 shared paper)Dong Moon Shin (3 shared papers)Fadlo Raja Khuri (3 shared papers)Robert C. Osorio (1 shared paper)Robert W. Osorio (1 shared paper)Catherine T Frenette (1 shared paper)Maha R. Boktour (1 shared paper)Jennifer E. Guy (1 shared paper)
- Journals
- Expert Opinion on Emerging Drugs (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)The Oncologist (2 papers)Clinical Epigenetics (1 paper)
- Partner nations
- United StatesChinaTürkiye
In The Last Decade
John C. Rhee
16 papers receiving 219 citations
Peers
Comparison fields: 5 of 62
- Hepatology 44
- Oncology 72
- Otorhinolaryngology 7
- Immunology 32
- Pathology and Forensic Medicine 22
Countries citing papers authored by John C. Rhee
This map shows the geographic impact of John C. Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Rhee more than expected).
Fields of papers citing papers by John C. Rhee
This network shows the impact of papers produced by John C. Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Rhee. The network helps show where John C. Rhee may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 47 | |
| 2 | 1994 | 40 | |
| 3 | 2014 | 37 | |
| 4 | 2004 | 30 | |
| 5 | 2005 | 12 | |
| 6 | 2023 | 12 | |
| 7 | 2005 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2024 | 8 | |
| 10 | 2025 | 5 | |
| 11 | 2021 | 4 | |
| 12 | 2017 | 3 | |
| 13 | 2004 | 3 | |
| 14 | 2004 | 3 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 |
About John C. Rhee
John C. Rhee is a scholar working on Oncology, Hepatology, Otorhinolaryngology, Immunology and Reproductive Medicine, having authored 16 papers that have together received 225 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Head and Neck Cancer Studies (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (2 papers), Biomedical Ethics and Regulation (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Hepatology (44 citations), Oncology (72 citations), Otorhinolaryngology (7 citations), Immunology (32 citations) and Pathology and Forensic Medicine (22 citations). John C. Rhee has collaborated with scholars based in United States, China and Türkiye. Frequent co-authors include William Lee Smith, Dong Moon Shin, Fadlo Raja Khuri, Robert C. Osorio, Robert W. Osorio, Catherine T Frenette, Maha R. Boktour, Jennifer E. Guy, Brian Irving Carr and Reetesh K. Pai. Their work appears in journals such as Expert Opinion on Emerging Drugs, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, The Oncologist and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.